Behind the Study: Predictive miRNA Signature and Breast Cancer
Researchers from the University of Vermont discuss their study, published by Oncotarget in 2017, titled, "... read more
March 29, 2021
Author: Oncotarget
Behind the Study: LINC00520 and Breast Cancer
The Behind the Study series transcribes videos of researchers elaborating on their papers... read more
March 22, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #6
Read short summaries of the latest research literature published by Oncotarget.Origin: Missouri,... read more
March 16, 2021
Behind the Study: Phenanthrene and Human Pancreatic Cancer Cells
Senior researcher, Professor Malka Cohen-Armon, describes the study she co-authored in Oncotarget entitled, “The phenanthrene... read more
March 15, 2021
Behind the Study: Melatonin and Prostate Cancer
Professor Vladimir Anisimov details the study he co-authored in an Oncotarget publication, titled: “Melatonin increases... read more
March 11, 2021
Behind the Study: New Clues for Targeting Drug Resistant Colon Cancers
Dr. Bruce Boman from the Helen F. Graham Cancer Center describes the findings in a... read more
March 8, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #5
Read short summaries of the latest research literature published by Oncotarget.Origin: New... read more
March 2, 2021
Behind the Study: Cancer Stem Cells and Macrophages
Dr. Beatrice Aramini and Dr. Valentina Masciale provide an overview of their cancer research published... read more
February 22, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #4
Read short summaries of the latest research literature published by Oncotarget.Origin: Maryland, Minnesota,&... read more
February 16, 2021
Behind the Study: Statins Primary Mode of Action Against Cancer Cells
Neuro-oncologist physician-scientist Dr. Benjamin Purow describes the findings in a paper he helped author in... read more
February 15, 2021